We focused on sites manufacturing facilities is during active pharmaceutical ingredient (API) identified as being in areas with greater exposure to water scarcity, and medicine production, with a significant proportion of this associated which have provided local insights as to water use at these sites and with the utilities and auxiliary equipment needed to create the right will support and guide our ongoing work in this area.